KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Non-Current Liabilities (2016 - 2025)

Alnylam Pharmaceuticals' Other Non-Current Liabilities history spans 16 years, with the latest figure at $7.6 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 98.07% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $7.6 million, down 98.07%, while the annual FY2025 figure was $7.6 million, 98.07% down from the prior year.
  • Other Non-Current Liabilities reached $7.6 million in Q4 2025 per ALNY's latest filing, down from $9.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $407.5 million in Q2 2025 to a low of $5.9 million in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $195.2 million, with a median of $197.8 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 557.33% in 2021, then tumbled 98.17% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $99.0 million in 2021, then surged by 114.81% to $212.6 million in 2022, then surged by 45.09% to $308.4 million in 2023, then rose by 27.45% to $393.1 million in 2024, then plummeted by 98.07% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Other Non-Current Liabilities are $7.6 million (Q4 2025), $9.8 million (Q3 2025), and $407.5 million (Q2 2025).